8:34 PM ET
Form 4
Insider Selling
Halozyme Therapeutics President and CEO Helen Torley Sells $6M of Stock
Helen Torley, President and CEO, sold 60,000 shares of Halozyme Therapeutics, Inc. at $96.85 to $101.72 a share (average $100.01) in 10 transactions, worth $6M in total between Nov 12, 2026 and Nov 16, 2026. Shares held after the trade: 767,780 (-0.0%).
- Value
- $6M
- Shares
- 60,000
- Average price
- $100.01
- Role
- President and CEO
- Holding change
- -0.0%
- Trade date
- Nov 12, 2026 to Nov 16, 2026